NuVasive in its all-stock combination with Globus Medical

On February 9th, 2023, NuVasive (NASDAQ: NUVA), the leader in spine technology innovation, and Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, announced they have entered into a definitive agreement to combine in a $3.1 billion all-stock transaction.

Wachtell, Lipton, Rosen & Katz is serving as legal advisor to NuVasive.